Searched for
GMPS
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...- 5 IPOs to open this week. Check GMPs to track listing sentimentsIndia’s primary market will see five IPOs open next week, including four mainboard issues and one SME offering, but weak grey market premiu...
- 7 out of last 8 mainboard IPOs delivered negative listing gains. What is going wrong with India’s IPO market?India’s IPO market is showing signs of cooling, with seven of the last eight mainboard listings delivering negative debut gains. Weak broad...
- ICICI Pru AMC IPO: 7.4% GMP signals strong investor appetite as issue opens for bidding todayICICI Pru AMC’s IPO opened to strong sentiment, with a steady GMP of Rs 160–165 indicating a potential 7.4% listing gain. The robust premiu...
- Wework India to Infinity Infoway: 5 IPOs that could offer up to 33% return next weekGrey Market Premiums (GMPs) offer a quick snapshot of sentiment, though they are unofficial and not always an indicator of listing-day perf...
- 9 IPOs opening this week see GMPs from 0 to 107%. Check for all issuesIt will be a packed week for primary markets with nine IPOs opening for subscription across mainboard and SME platforms. From marquee names...
- Should investors subscribe to the upcoming NSDL IPO amid market uncertainty?Analysts suggest investors consider subscribing to National Securities Depository's (NSDL) upcoming IPO, citing its attractive pricing comp...
- Grey market buzzing with flurry of public issues, improved sentimentGrey market premiums (GMPs) - the additional price investors are willing to pay over the IPO price in the grey market before the stock list...
- These 2 soon-to-list SME IPOs are boasting a GMP of over 100% despite NSE price capGanesh Green Bharat is enjoying a GMP approximately 120% higher than its issue price, while Effwa Infra is seeing a premium of nearly 146% ...
- Rx quality control for reputation and livesReplace the existing regulatory system with a modern legal structure that provides oversight to an increasingly complex pharma industry, wh...
- USFDA gives exception to Glenmark Pharma to supply pneumonia drug from Baddi facilityIn a regulatory filing, Glenmark said, "...due to medical necessity and potential drug shortage expectations, the USFDA has provided an exc...
- Prescribe, formulate a drug recall lawIndia must quickly formulate a law backed by Parliament for recalling medicines that are found to flout GMPs or contain adulterated active ...
- USFDA issues import alert on Glenmark Pharma's Baddi plantThe US Food and Drug Administration inspected the facility in June 2022 and subsequently placed it under "Official Action Indicated" status.
- Fleming Lab's Nawabpet facility comes under USFDA scannerEstablished in 1995, Fleming Laboratories is in the business of manufacturing and supply of generic Active Pharmaceutical Ingredients (APIs...
- USFDA to lift import alert on Visakhapatnam unit: Divi's LabsDivi's Laboratories has been informed by the USFDA that it will lift the Import Alert 99-32 imposed on the company's Unit-II at Visakhapatn...
- USFDA issues import alert against medicines made by Pan DrugsThe US health regulator has issued an import alert for the human and animal medicines made by Gujarat-based Pan Drugs Ltd for violation of ...
- Questions on data integrity undermines framework of trust: Richard Johnson, PDAIn all of the activities of PDA worldwide, we work to identify best practices and target continuous improvement in pharmaceutical processes.
- USFDA issues import alert against Emcure Pharma's Pune plantUS health regulator has issued an import alert against Pune-based Emcure Pharmaceuticals for products made at its plant in Hinjwadi, Pune.
- Jubilant Life Sciences plunges 10% on USFDA warning letterJubilant Life Sciences was witnessing selling pressure after one of its manufacturing facilities in the US, was issued a warning letter (WL...
- GMPs may take toll on drug exportsIn what could hit the country’s vaccine exports estimated to be at Rs 1,500 crore, besides maligning the reputation of Indian companies, WH...
Load More
